Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Second Parkinson’s Vaccine Reports Positive Safety Results

    Positive News for COVID-19 Vaccines: What Does It Mean for the Parkinson’s Community?

    Trials of two COVID-19 vaccines recently reported the vaccines are highly effective in preventing infection. Read more about this news and what it means for people with Parkinson’s.
    Learn more
  • Two researchers in a lab

    Trial Testing Dyskinesia Drug Moves Forward with Support from Global Parkinson’s Organizations

    The Michael J. Fox Foundation is collaborating with Parkinson’s UK to fund a Phase II clinical trial of a new drug called NLX-112 with biopharma company Neurolixis.
    Learn more
  • Default content image

    Foundation Confers Edmond J. Safra Humanitarian Award to Lily Safra and Honors Distinguished Scientists with 2020 Major Research Prizes

    The Foundation honored two researchers for their groundbreaking work in Parkinson's disease and dystonia research and announced a new humanitarian award on November 17, 2020.
    Learn more
  • Samples in the lab

    PPMI Dispatch: Landmark Study Opens Enrollment While Analysis Points to Potential Blood Test for Parkinson’s

    Some sites are enrolling new volunteers into our Parkinson’s Progression Markers Initiative, and scientists are getting closer to a blood test to track disease progression.
    Learn more
  • What We Fund: $6 Million in New Grants for Parkinson’s Research

    Alzheimer’s Drug Aducanumab Back in the News

    An advisory panel recently recommended against approval of aducanumab, which aims to slow Alzheimer’s, citing lack of solid evidence. Now the FDA decides.
    Learn more
  • Breaking News: New Dyskinesia Drug Submitted to FDA

    News in Context: A Diabetes Drug for Parkinson’s?

    New research suggests that people with diabetes who take exenatide, a drug in testing for possible benefit in PD, have a lower risk of Parkinson’s.
    Learn more
  • Urge Congress to Safeguard Medicare Funding

    What We Fund: $7.3M for New Cognition Trial, Parkinson’s Protein Measures and More

    The Michael J. Fox Foundation issued 33 new grants in August and September toward new treatments, better ways to measure Parkinson’s and deeper understanding of the disease.
    Learn more
Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD CEO
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.